Abstract: Glucose exposure can be indicative of a number of potential underlying health conditions. The present disclosure is directed to measuring glucose exposure, determined, for example, on an hourly basis. This glucose exposure, in at least one embodiment, represents a current glucose level over the span of given period (e.g., a portion of 24 hours). If a patient's glucose exposure exceeds a glucose threshold or limit (for a 24 hour period in some embodiments), then a variety of treatments may be administered to the patient to help lower overall glucose exposure (e.g., during the 24 hour period).

Abstract: Disclosed herein are systems and processes for measuring, monitoring, processing, and visualizing biological data including blood glucose levels. In various embodiments, a biomarker monitoring fitness system may facilitate one or more of the monitoring of fitness data including blood glucose levels measured by continuous glucose monitoring (CGM) sensor for an individual user or group of users, the prediction of carbohydrate intake needs or insulin delivery needs during physical activity of a user and the active indication thereof to the user and/or a delivery system of the user, and the collection and management of de-identified and identifiable user fitness data including blood glucose data.